Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07455136 · ClinicalTrials.gov registry record
A Study to Develop a Blood-based Test for Aiding the Diagnosis/Prognosis of Traumatic Brain Injury in Adults and for Monitoring the Development of Secondary Events in Patients Diagnosed With Traumatic Brain Injury
A clinical trial of Traumatic Brain Injury, sponsored by Hoffmann-La Roche.
- Recruiting
- Registry status
- 2,000
- Enrollment target
- 9
- Study locations
NCT07455136: Recruiting study of Traumatic Brain Injury, sponsored by Hoffmann-La Roche.
NCT07455136 is a study of Traumatic Brain Injury that is actively recruiting participants, run by Hoffmann-La Roche. The registered enrollment target is 2,000 participants, above the 266-participant average among 171 other Traumatic Brain Injury trials with a reported enrollment target (652% higher). The trial reports 9 study locations across 7 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07455136, a study of Traumatic Brain Injury, is actively recruiting participants, sponsored by Hoffmann-La Roche.
- RECRUITING
- Registry status
- 2,000 participants
- Enrollment target
- 9
- Study locations
Study Summary
The study is intended to cover two purposes: first, to develop a blood-based biomarker test for aiding the diagnosis of traumatic brain injury (TBI) in adult participants and for prognosis of outcome of TBI (CLIN12.1); and second, for monitoring the development of secondary events in adult participants diagnosed with TBI (CLIN12.2).
Conditions Studied
Interventions
- PROCEDURE Blood sample collection
Study Locations (9)
California
- University Of California Davis, Neurological Surgery - Sacramento
- University of California San Francisco - San Francisco
Pennsylvania
- University of Pennsylvania Medical Center - Philadelphia
- University of Pittsburgh Medical Center - Pittsburgh
Indiana
- Goodman Campbell Brain and Spine/Ascension - Carmel
North Carolina
- Atrium Health - Carolina Medical Center - Charlotte
Ohio
- University of Cincinnati - Cincinnati
Tennessee
- Vanderbilt University Medical Center - Nashville
Wisconsin
- Medical College of Wisconsin - Milwaukee
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,000 participants |
| Start Date | 2026-02-09 |
| Est. Completion | 2028-05-31 |
What NCT07455136 shows while recruiting
NCT07455136 is an observational study that tracks outcomes without assigning an intervention. Its 2,000 participants enrollment target places it among the larger protocols in the corpus, above the 266-participant average among 171 other Traumatic Brain Injury trials with a reported enrollment target (652% higher).
The record links to 1 condition, with Traumatic Brain Injury appearing as the primary indexed condition, and to 1 intervention - of which Blood sample collection is the first listed.
NCT07455136 lists 9 locations in 7 states (California, Pennsylvania, Indiana).
Frequently Asked Questions
What is clinical trial NCT07455136 about?
NCT07455136 is a clinical study titled "A Study to Develop a Blood-based Test for Aiding the Diagnosis/Prognosis of Traumatic Brain Injury in Adults and for Monitoring the Development of Secondary Events in Patients Diagnosed With Traumatic Brain Injury". The study is intended to cover two purposes: first, to develop a blood-based biomarker test for aiding the diagnosis of traumatic brain injury (TBI) in adult participants and for prognosis of outcome of TBI (CLIN12.1); and second, for monitoring the development of secondary events in adult participa...
What is the current status of trial NCT07455136?
This trial is currently recruiting. The enrollment target is 2,000 participants. The study started on 2026-02-09. Estimated completion is 2028-05-31.
What conditions does trial NCT07455136 study?
This clinical trial studies the following conditions: Traumatic Brain Injury.
What interventions are being tested in trial NCT07455136?
The interventions under investigation include: Blood sample collection (PROCEDURE).
Who is sponsoring clinical trial NCT07455136?
This trial is sponsored by Hoffmann-La Roche, which has 909 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07455136 being conducted?
This trial has 9 study locations across California, Indiana, North Carolina, Ohio, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Traumatic Brain Injury
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07455136's enrollment target sits among peer trials
2,000 3rd of 171 higher than 166 of 171 other Traumatic Brain Injury trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Traumatic Brain Injury trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
tPBM in Older Adults With Traumatic Brain Injury
RECRUITING · NA
-
Hyperpolarized 13C-pyruvate Metabolic MRI With Traumatic Brain Injury
RECRUITING · Phase 1
-
Carbon Dioxide Administration and Brain Waste Clearance
RECRUITING · NA
-
TMS-fNIRS Personalized Dosing
RECRUITING · NA
-
Cortical Spreading Depolarization After Severe Traumatic Brain Injury
RECRUITING
-
A Study to Evaluate the SENSE Device's Ability to Detect TBI
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001465 · 2,000 participants
Study of the Disease Process of Lymphangioleiomyomatosis
- NCT00001595 · 2,000 participants
An Investigation of Pituitary Tumors and Related Hypothalmic Disorders
- NCT00138931 · 2,000 participants
Genetics of Cardiovascular and Neuromuscular Disease
- NCT00288119 · 2,000 participants
Genetic Determinants of Barrett's Esophagus and Esophageal Adenocarcinoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI